199 related articles for article (PubMed ID: 15639720)
1. Anticoagulant drugs increase natural killer cell activity in lung cancer.
Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
[TBL] [Abstract][Full Text] [Related]
2. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adhesion breast cancer cells by anticoagulant drugs and cimetidine.
Bobek V; Boubelik M; Kovarík J; Taltynov O
Neoplasma; 2003; 50(2):148-51. PubMed ID: 12740651
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
[TBL] [Abstract][Full Text] [Related]
6. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
7. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
9. [Effect of surgical treatment on the natural killer activity in lung cancer patients].
Ancheva M; Boeva M; Tenev V
Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129
[TBL] [Abstract][Full Text] [Related]
10. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells.
Nielsen LR; Kimose HH; Linnet L; Møller NP; Bukh A
J Clin Lab Immunol; 1989 Jun; 29(2):71-7. PubMed ID: 2632804
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
13. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12-mediated killer activity in lung cancer patients.
Haku T; Yanagawa H; Nabioullin R; Takeuchi E; Sone S
Cytokine; 1997 Nov; 9(11):846-52. PubMed ID: 9367545
[TBL] [Abstract][Full Text] [Related]
15. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA
Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer activity and mechanistic features of a NK cell activating molecule.
Kim HR; Lee KH; Park SJ; Kim SY; Yang YK; Tae J; Kim J
Cancer Immunol Immunother; 2009 Oct; 58(10):1691-700. PubMed ID: 19259669
[TBL] [Abstract][Full Text] [Related]
18. [The effect of local hyperthermia on NK activity and lung metastasis in mice].
Hu Y; Wang J; Lu S
Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):582-4. PubMed ID: 9275469
[TBL] [Abstract][Full Text] [Related]
19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
